US 9745585
RNAi-mediated inhibition of histamine receptor H1-related conditions
granted A61PA61P11/02A61P11/06
Quick answer
US patent 9745585 (RNAi-mediated inhibition of histamine receptor H1-related conditions) held by Arrowhead Pharmaceuticals, Inc. expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P11/02, A61P11/06, A61P17/00, A61P27/02